These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9186532)

  • 21. Resistance to activated protein C, highly prevalent amongst users of oral contraceptives with venous thromboembolism.
    Bennet L; Odeberg H
    J Intern Med; 1998 Jul; 244(1):27-32. PubMed ID: 9698021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factor V antigen levels in APC resistance, in factor V deficiency and in combined APC resistance and factor V deficiency (pseudohomozygosis for APC resistance).
    Girolami A; Simioni P; Venturelli U; Girolami B; Zanon E
    Blood Coagul Fibrinolysis; 1997 Jun; 8(4):245-8. PubMed ID: 9199822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of oral contraceptives on hemostasis and thrombosis.
    Rosing J; Tans G
    Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S375-82. PubMed ID: 10368524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased risk for venous thrombosis in carriers of the prothrombin G-->A20210 gene variant.
    Margaglione M; Brancaccio V; Giuliani N; D'Andrea G; Cappucci G; Iannaccone L; Vecchione G; Grandone E; Di Minno G
    Ann Intern Med; 1998 Jul; 129(2):89-93. PubMed ID: 9669991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of factor VIII/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation.
    De Mitrio V; Marino R; Scaraggi FA; Di Bari L; Giannoccaro F; Petronelli M; Ranieri P; Tannoia N; Schiraldi O
    Blood Coagul Fibrinolysis; 1999 Oct; 10(7):409-16. PubMed ID: 10695766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel factor V null mutation detected in a thrombophilic patient with pseudo-homozygous APC resistance and in an asymptomatic unrelated subject.
    Lunghi B; Castoldi E; Mingozzi F; Bernardi F; Castaman G
    Blood; 1998 Aug; 92(4):1463-4. PubMed ID: 9694743
    [No Abstract]   [Full Text] [Related]  

  • 27. Thrombosis in patients with heterozygous and homozygous factor XII deficiency is not explained by the associated presence of factor V Leiden.
    Castaman G; Ruggeri M; Tosetto A; Missiaglia E; Rodeghiero F
    Thromb Haemost; 1996 Aug; 76(2):275. PubMed ID: 8865545
    [No Abstract]   [Full Text] [Related]  

  • 28. Rapid two-stage PCR for detecting factor V G1691A mutation.
    Beauchamp NJ; Daly ME; Cooper PC; Preston FE; Peake IR
    Lancet; 1994 Sep; 344(8923):694-5. PubMed ID: 7915391
    [No Abstract]   [Full Text] [Related]  

  • 29. APC-resistance as measured by a Textarin time assay: comparison to the APTT-based method.
    Hoagland LE; Triplett DA; Peng F; Barna L
    Thromb Res; 1996 Sep; 83(5):363-73. PubMed ID: 8873345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular detection of a common mutation in coagulation factor V causing thrombosis via hereditary resistance to activated protein C.
    Liu XY; Nelson D; Grant C; Morthland V; Goodnight SH; Press RD
    Diagn Mol Pathol; 1995 Sep; 4(3):191-7. PubMed ID: 7493138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of original and modified APC-resistance tests in unselected outpatients with clinically suspected thrombosis and in healthy controls.
    Svensson PJ; Zöller B; Dahlbäck B
    Thromb Haemost; 1997 Feb; 77(2):332-5. PubMed ID: 9157592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis strategies in activated protein C resistance: is genotyping still necessary?
    Biron C; Lamarti H; Schved JF; Jeanjean P; Masmejean C; Claustres M; Aguilar-Martinez P
    Clin Lab Haematol; 1997 Mar; 19(1):67-71. PubMed ID: 9146951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening.
    Ridker PM; Miletich JP; Hennekens CH; Buring JE
    JAMA; 1997 Apr 23-30; 277(16):1305-7. PubMed ID: 9109469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inherited resistance to activated protein C caused by presence of the FV:Q506 allele as a basis of venous thrombosis.
    Dahlbäck B; Zöller B; Hillarp A
    Haemostasis; 1996 Oct; 26 Suppl 4():301-14. PubMed ID: 8979136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Activated protein C resistance and venous thrombophilia: molecular genetic prevalence study in the German population].
    Ehrenforth S; Klinke S; von Depka Prondzinski M; Kreuz W; Ganser A; Scharrer I
    Dtsch Med Wochenschr; 1999 Jun; 124(25-26):783-7. PubMed ID: 10414227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alternative PCR method for diagnosis of mutation causing activated protein C resistant Gln506-factor V.
    Greengard JS; Xu X; Gandrille S; Griffin JH
    Thromb Res; 1995 Dec; 80(5):441-3. PubMed ID: 8588206
    [No Abstract]   [Full Text] [Related]  

  • 37. Identification and functional characterization of a novel F5 mutation (Ala512Val, FVB onn ) associated with activated protein C resistance.
    Pezeshkpoor B; Castoldi E; Mahler A; Hanel D; Müller J; Hamedani NS; Biswas A; Oldenburg J; Pavlova A
    J Thromb Haemost; 2016 Jul; 14(7):1353-63. PubMed ID: 27090446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prothrombin fragment 1+2 and thrombin-antithrombin complex levels in patients with inherited APC resistance due to factor V Leiden mutation.
    Simioni P; Scarano L; Gavasso S; Sardella C; Girolami B; Scudeller A; Girolami A
    Br J Haematol; 1996 Feb; 92(2):435-41. PubMed ID: 8603014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Activated protein C resistance--an evaluation of current status].
    Hopmeier P
    Wien Klin Wochenschr; 1996; 108(19):599-606. PubMed ID: 9012145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modified APC-resistance test: variable ratios with respect to source of factor V-deficient plasma.
    Ts'ao C; Neofotistos D; Oropeza M; Vahabinejad S; Finn WG
    Am J Hematol; 1997 Mar; 54(3):214-8. PubMed ID: 9067500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.